PHAT
NASDAQ · Pharmaceuticals
Phathom Pharmaceuticals Inc
$10.88
-0.12 (-1.09%)
Open$11.24
Previous Close$11.00
Day High$11.40
Day Low$10.59
52W High$18.31
52W Low$7.61
Volume—
Avg Volume825.6K
Market Cap867.74M
P/E Ratio—
EPS$-2.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+366.4% upside
Current
$10.88
$10.88
Target
$50.74
$50.74
$34.41
$50.74 avg
$70.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 200.95M | 173.93M | 162.51M |
| Net Income | -253,896,925 | 52.15M | 46.06M |
| Profit Margin | -126.4% | 30.0% | 28.4% |
| EBITDA | -182,862,353 | 99.13M | 88.44M |
| Free Cash Flow | — | 45.89M | 35.44M |
| Rev Growth | — | -4.6% | -5.1% |
| Debt/Equity | 1.24 | 0.67 | 0.68 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |